These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 6603514

  • 1. The calcium dependence of spontaneous and evoked quantal release at the frog neuromuscular junction.
    Barton SB, Cohen IS, van der Kloot W.
    J Physiol; 1983 Apr; 337():735-51. PubMed ID: 6603514
    [Abstract] [Full Text] [Related]

  • 2. Time course and magnitude of effects of changes in tonicity on acetylcholine release at frog neuromuscular junction.
    Kita H, van der Kloot W.
    J Neurophysiol; 1977 Mar; 40(2):212-24. PubMed ID: 300428
    [Abstract] [Full Text] [Related]

  • 3. The relation between tonicity and impulse-evoked transmitter release in the frog.
    Kita H, Narita K, Van der Kloot W.
    J Physiol; 1982 Apr; 325():213-22. PubMed ID: 6286938
    [Abstract] [Full Text] [Related]

  • 4. Effects of lectins on quantal release at the frog neuromuscular junction.
    Gu XQ, van der Kloot W.
    Neuroscience; 1992 Apr; 47(3):649-56. PubMed ID: 1584412
    [Abstract] [Full Text] [Related]

  • 5. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF, Barrett JN, Botz D, Chang DB, Mahaffey D.
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [Abstract] [Full Text] [Related]

  • 6. Calcium dependence of evoked transmitter release at very low quantal contents at the frog neuromuscular junction.
    Andreu R, Barrett EF.
    J Physiol; 1980 Nov; 308():79-97. PubMed ID: 6112267
    [Abstract] [Full Text] [Related]

  • 7. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC.
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [Abstract] [Full Text] [Related]

  • 8. Changes in miniature end-plate potentials due to moderate hypertonicity at the frog neuromuscular junction.
    Doherty P, Hawgood BJ, Smith IC.
    J Physiol; 1986 Jul; 376():1-11. PubMed ID: 3491900
    [Abstract] [Full Text] [Related]

  • 9. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ, Levitan H.
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG, Lundh H, Thesleff S.
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [Abstract] [Full Text] [Related]

  • 12. Activity increases quantal size at the frog neuromuscular junction.
    Van der Kloot W, Van der Kloot TE.
    Experientia; 1985 Jan 15; 41(1):47-8. PubMed ID: 3871401
    [Abstract] [Full Text] [Related]

  • 13. Observations on the action of type A botulinum toxin on frog neuromuscular junctions.
    Boroff DA, del Castillo J, Evoy WH, Steinhardt RA.
    J Physiol; 1974 Jul 15; 240(2):227-53. PubMed ID: 4371582
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J, del Pozo E, Baños JE, Angaut-Petit D.
    Br J Pharmacol; 1991 Sep 15; 104(1):133-8. PubMed ID: 1686201
    [Abstract] [Full Text] [Related]

  • 16. Effects of the ionophore X-537A on acetylcholine release at the frog neuromuscular junction.
    Kita H, Van Der Kloot W.
    J Physiol; 1976 Jul 15; 259(1):177-98. PubMed ID: 182959
    [Abstract] [Full Text] [Related]

  • 17. Spontaneous and evoked transmitter releases after concanavalin A treatment are affected differently by hypertonic low calcium solutions at frog neuromuscular junction.
    Narita K, Kawasaki F, Kita H.
    Brain Res; 1990 Mar 26; 512(1):33-9. PubMed ID: 2337806
    [Abstract] [Full Text] [Related]

  • 18. Estimating the time course of evoked quantal release at the frog neuromuscular junction using end-plate current latencies.
    Baldo GJ, Cohen IS, Van der Kloot W.
    J Physiol; 1986 May 26; 374():503-13. PubMed ID: 3489094
    [Abstract] [Full Text] [Related]

  • 19. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W.
    J Physiol; 1993 Aug 26; 468():567-89. PubMed ID: 8254525
    [Abstract] [Full Text] [Related]

  • 20. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD.
    J Physiol; 1975 Aug 26; 250(1):121-42. PubMed ID: 240928
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.